Kaposi's sarcoma in HIV infection: Impact on opportunistic infections and survival

AIDS

Volumn 12, Issue 12, 1998, Pages 1475-1481

  Brodt, Hans Reinhard ^a   Kamps, Bernd S ^a   Helm, Eilke B ^a   Schöfer, Helmut ^a   Mitrou, Paris ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

AIDS; Case control study; HIV; Kaposi's sarcoma; Natural history; Opportunistic infection; Retrospective; Survival

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; HOMOSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHOCYTE COUNT; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; SARCOMA, KAPOSI;

EID: 0032552168     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199812000-00009     Document Type: Article

References (35)

1. Des Jarlais DC, Stoneburner R, Thomas P: Declines in proportion of Kaposi's sarcoma among cases of AIDS in multiple risk groups in New York City. Lancet 1987, ii:1024-1025.
2. Kaldor JM, Tindall B, Williamson P, Elford J, Cooper DA: Factors associated with Kaposi's sarcoma in a cohort of homosexual and bisexual men. J Acquir Immun Defic Syndr 1993, 6:1145-1149.
3. Lifson AR, Darrow WW, Hessol NA, et al.: Kaposi's sarcoma in a cohort of homosexual and bisexual men. Am J Epidemiol 1990, 131:221-231.
4. Lundgren JD, Melbye M, Pedersen C, Rosenberg PS, Gerstoft J: Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow up. Am J Epidemiol 1995, 141:652-658.
5. Montaner JSC, Le T, Hogg R, et al.: The changing spectrum of AIDS index diseases in Canada. AIDS 1994, 8:693-696.
6. Peters BS, Beck EJ, Coleman DC, et al.: Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ 1991, 302:203-207.
7. Rutherford CW, Schwarcz SK, Lemp CF: The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco. J Infect Dis 1989, 159:569-572.
8. Dore GJ, Li Y, Grulich AE, et al.: Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohort. AIDS 1996, 10:1401-1406.
9. Selik RM, Chu SY, Ward JW: Trends in infectious disease and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann Intern Med 1995, 123:933-936.
10. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE: Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group. Arch Intern Med 1994, 154: 566-572.
11. Lemp GF, Payne SF, Neal D, Temelso T, Rutherford GW: Survival trends for patients with AIDS. JAMA 1990, 263:402-406.
12. Payne SF, Lemp CF, Rutherford GW: Survival following diagnosis of oral Kaposi's sarcoma for AIDS patients in San Francisco. J Acquir Immune Defic Syndr 1990, 3:S14-S17.
13. Miles SA, Wang H, Elashoff R, Mitsuyasu RT: Improved survival for patients with AIDS-related Kaposi's sarcoma. J Clin Oncol 1994, 12:1910-1916.
14. Mole L, Ripich S, Margolis D, Holodniy M: The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997, 176:766-770.
15. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41 (RR-17):1-19.
16. Mitrou PS: Management of Kaposi's sarcoma. Onkologie 1996, 19:49-52.
17. Rothman KJ, Greenland S: Modern Epidemiology. Philadelphia: Lippintott-Raven Publishers; 1998:153-175.
18. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
19. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York: Wiley; 1980.
20. Mocroft AJ, Lundgren JD, d'Armino Monforte A, et al.: Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. Int J Epidemiol 1997, 26:400-407.
21. Luo K, Law M, Kaldor JM, McDonald AM, Cooper DA: The role of initial AIDS-defining illness in survival following AIDS. AIDS 1995, 9:57-63.
22. Padiglione A, Goldstein D, Law MC, Hoy JF, Kaldor JM, Mijch AM: Prognosis of Kaposi's sarcoma as an initial and later AIDS associated illness. Ann Oncol 1997, 8:871-875.
23. Nicholas J, Ruvolo VR, Burns WH, et al.: Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nature Med 1997, 3:287-292.
24. Harrington W, Sieczkowski JR, Sosa C, et al.: Activation of HHV-8 by HIV-1 Tat. Lancet 1997, 349:774-775.
25. Rizzieri DA, Liu J, Traweek ST, Miralles GD: Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor. Lancet 1997, 349:775-776.
26. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB: Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997, 11: 1731-1738.
27. Chang Y, Cesarman L, Pessin MS, et al.: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1864-1869.
28. Dupin N, Grandadam M, Calvez V, et al.: Herpesvirus-like DNA sequences in patients with mediterranean Kaposi's sarcoma. Lancet 1995, 345:761-762.
29. Gao SJ, Kingsley L, Hoover DR, et al.: Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996, 335:233-241.
30. Moore PS, Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995, 332:1181-1185.
31. Glesby MJ, Hoover DR, Weng S, et al.: Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the multicenter AIDS cohort study. J Infect Dis 1996, 173:1477-1480.
32. Jones JL, Hanson DL, Chu SY, Ward JWX, Jaffe HW: AIDS-associated Kaposi's sarcoma. Science 1995, 267:1078-1079.
33. Morfeldt L, Torssander J: Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scand J Infect Dis 1994, 26:749-752.
34. Medveczky MM, Horvarth E, Lund T, Medveczky PG: In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS 1997, 11:1327-1332.
35. Mocroft A, Youle M, Cazzard B, et al.: Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. AIDS 1996, 10:1101-1105.